IRIS
PORZIO, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.816
AS - Asia 3.082
EU - Europa 2.776
SA - Sud America 508
Continente sconosciuto - Info sul continente non disponibili 116
AF - Africa 65
OC - Oceania 9
Totale 12.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.717
SG - Singapore 1.279
IE - Irlanda 703
CN - Cina 695
RU - Federazione Russa 633
BR - Brasile 426
TR - Turchia 365
DE - Germania 343
HK - Hong Kong 316
VN - Vietnam 233
IT - Italia 192
UA - Ucraina 190
GB - Regno Unito 166
SE - Svezia 147
FI - Finlandia 106
FR - Francia 103
CA - Canada 52
CZ - Repubblica Ceca 43
IN - India 39
NL - Olanda 38
PL - Polonia 38
BD - Bangladesh 32
MX - Messico 28
JP - Giappone 25
BE - Belgio 23
MA - Marocco 22
ZA - Sudafrica 22
AR - Argentina 17
EC - Ecuador 15
IQ - Iraq 15
ES - Italia 11
CO - Colombia 10
PK - Pakistan 10
PY - Paraguay 10
UZ - Uzbekistan 10
VE - Venezuela 9
ID - Indonesia 8
PE - Perù 8
TN - Tunisia 8
IL - Israele 7
JO - Giordania 7
AU - Australia 6
CL - Cile 6
JM - Giamaica 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
MY - Malesia 5
PT - Portogallo 5
RS - Serbia 5
AT - Austria 4
AZ - Azerbaigian 4
BO - Bolivia 4
EU - Europa 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
BG - Bulgaria 3
DZ - Algeria 3
HN - Honduras 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
SA - Arabia Saudita 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CH - Svizzera 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 12.260
Salva come PNG Salva come JPEG
Città #
Chandler 712
Jacksonville 705
Dublin 703
Singapore 659
San Jose 592
Dallas 543
Ashburn 364
Hong Kong 313
Santa Clara 243
Boardman 225
The Dalles 171
Izmir 156
Ann Arbor 141
New York 119
Wilmington 113
Nanjing 112
Beijing 103
Lawrence 102
Princeton 102
Moscow 89
Council Bluffs 80
Ho Chi Minh City 76
Los Angeles 74
San Mateo 72
Munich 60
Columbus 50
Bremen 49
Lauterbourg 49
São Paulo 45
Dearborn 43
Brno 42
Hanoi 41
Shenyang 40
Seattle 39
Nanchang 37
Helsinki 35
Amsterdam 33
Milan 31
Warsaw 31
Woodbridge 27
Jinan 26
Montreal 26
L'aquila 25
Tokyo 25
Brussels 23
Frankfurt am Main 23
Tianjin 23
Atlanta 21
Des Moines 21
Hebei 20
Mountain View 20
Düsseldorf 19
Kunming 18
London 18
San Francisco 18
Stockholm 18
Casablanca 17
Johannesburg 17
Assago 16
Denver 16
Dong Ket 16
Orem 16
Brooklyn 15
Chennai 15
Hefei 15
Verona 15
Da Nang 14
Norwalk 14
Rome 14
Falkenstein 13
Ningbo 13
Phoenix 13
Zhengzhou 13
Chicago 12
Guangzhou 12
Haiphong 12
Jiaxing 12
Shanghai 12
Changsha 11
Mexico City 11
Philadelphia 11
Hải Dương 10
Belo Horizonte 9
Brasília 9
Buffalo 9
Nuremberg 9
Rio de Janeiro 9
Tashkent 9
Boston 8
Fortaleza 8
Monza 8
Poplar 8
Querétaro 8
Tappahannock 8
Toronto 8
Curitiba 7
Pune 7
Amman 6
Hangzhou 6
Houston 6
Totale 8.062
Salva come PNG Salva come JPEG
Nome #
The supportive care task force at the University of L'Aquila: 2-years experience 213
Epidemiology and Characteristics of Episodic Breathlessness In Advanced Cancer Patients: An Observational Study 176
Does pain intensity predict a poor opioid response in cancer patients? 171
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 169
Tapentadol in cancer pain management: a prospective open-label study 151
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 150
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 150
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 150
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 149
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 148
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 145
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 145
Pain evaluation and management: a survey of Italian radiotherapists 143
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 142
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 142
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients 140
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 139
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 138
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study 136
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 136
Efficacy of pregabalin in the management of cetuximab-related itch 135
Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine 135
Age differences in the last week of life in advanced cancer patients followed at home 134
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 134
Multimodality treatment in metastatic gastric cancer: From past to next future 134
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 131
What Is Known about Theragnostic Strategies in Colorectal Cancer 131
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 130
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 130
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 129
The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program 128
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 128
Breakthrough pain in oncology: A longitudinal study 127
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study 127
Assessment and treatment of symptoms among italian medical oncologists 126
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 126
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 126
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 125
Pain intensity as prognostic factor in cancer pain management 125
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 124
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 124
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 124
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 123
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 123
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 123
Dosing fentanyl buccal tablet for breakthrough cancer pain: Dose titration versus proportional doses 121
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 121
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 120
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy 120
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 119
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 118
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 117
Palliative sedation in patients with advanced cancer followed at home: A systematic review 117
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 116
Palliative radiotherapy in advanced cancer patients treated with immune‑checkpoint inhibitors: The PRACTICE study 116
Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen 116
Pattern of symptoms and symptomatic treatment in adults and the aged population: A retrospective analysis of advanced cancer patients followed at home 115
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study 115
Cancer care after natural disaster: Different countries, similar problems 115
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 114
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 114
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients 113
Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home. 111
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit 110
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 110
Validation of the pap score in advanced cancer patients who are candidates for palliative chemotherapy 110
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 110
Palliative care in advanced cancer patients: how and when? And where? 109
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 109
Prognostic factors of survival in patients with advanced cancer admitted to home care 109
Physical Exercise and Quality of Life in Breast Cancer Survivors 108
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 107
Morphine in the treatment of incident pain triggered by vinorelbine infusion 107
Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients 107
How do cancer patients receiving palliative care at home die? A descriptive study 107
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen 107
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy 107
Palliative sedation in advanced cancer patients followed at home: A retrospective analysis 106
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study 104
Palliative sedation in patients with advanced cancer followed at home: A prospective study 103
Rapid resolution of refractory chemotherapy induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report 102
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 102
Palliative sedation at home: A medical act practicable everywhere 100
Orphan symptoms in advanced cancer patients followed at home 99
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain 97
Integration between oncology and palliative care: A plan for the next decade? 97
Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors 95
Supporto nutrizionale 94
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 94
Re. “Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey” 94
Pharmacokinetics in pelvic stop-flow infusion and hypoxic pelvic perfusion with and without hemofiltration. 93
Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting 92
Is there a role for neurologist in an oncological home care team? 90
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis 89
Topical morphine in the treatment of painful ulcers 89
Emergencies in patients with advanced cancer followed at home 88
Tumori Ginecologici 88
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a web based online survey among Italian experts on supportive care in cancer 86
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron 84
"palliative" or "supportive": Is It Just a Matter of Word? 82
Totale 12.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022451 0 24 46 21 27 6 11 41 36 6 40 193
2022/20232.108 133 151 32 237 192 200 2 137 898 14 61 51
2023/2024452 63 24 22 48 37 114 3 33 1 25 16 66
2024/20252.361 60 35 169 131 356 203 370 173 475 110 165 114
2025/20264.068 225 430 375 512 401 326 617 128 377 489 159 29
2026/2027226 124 102 0 0 0 0 0 0 0 0 0 0
Totale 12.372